Ås, Norway

Ole Rasmus Ødegaard

This inventor holds 1 USPTO granted patent. Top assignee: Hepmarin as. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ole Rasmus Ødegaard. Retrieved from https://idiyas.com/inventor/ole-rasmus-ødegaard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ole Rasmus Ødegaard: Innovator in Anticoagulant Research

Introduction

Ole Rasmus Ødegaard is a notable inventor based in Ås, Norway. He has made significant contributions to the field of biomedical research, particularly in the development of anticoagulant substances derived from fish. His innovative work has the potential to impact medical treatments and improve patient outcomes.

Latest Patents

Ole Rasmus Ødegaard holds a patent for "Glycosaminoglycan anticoagulants derived from fish." This invention provides anticoagulant piscine gill glucosaminoglycans, which are high-affinity anticoagulant substances extractable from salmon guts, skin, tail, or gills, along with their salts and derivatives. This patent represents a significant advancement in the field of anticoagulant research.

Career Highlights

Throughout his career, Ødegaard has focused on the intersection of marine biology and medicine. His work at Hepmarin AS has allowed him to explore the therapeutic potential of fish-derived compounds. His dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

He has collaborated with notable colleagues, including Per Olav Skjervold and Frank Brosstad. These partnerships have fostered a collaborative environment that enhances the research and development of new biomedical solutions.

Conclusion

Ole Rasmus Ødegaard's contributions to anticoagulant research highlight the importance of innovation in medicine. His work not only advances scientific knowledge but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…